Deutsche Bank
CSTL icon

Deutsche Bank’s Castle Biosciences CSTL Stock Holding History

Deutsche Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719K Buy
30,139
+5,975
+25% +$133K ﹤0.01% 2568
2026
Q1 		$593K Buy
24,164
+1,780
+8% +$58.3K ﹤0.01% 2486
2025
Q4 		$871K Buy
22,384
+5,742
+35% +$185K ﹤0.01% 2259
2025
Q3 		$379K Sell
16,642
-45,101
-73% -$916K ﹤0.01% 2695
2025
Q2 		$1.26M Sell
61,743
-3,794
-6% -$70.2K ﹤0.01% 1949
2025
Q1 		$1.31M Sell
65,537
-2,130
-3% -$52.7K ﹤0.01% 2005
2024
Q4 		$1.8M Buy
67,667
+7,495
+12% +$228K ﹤0.01% 1917
2024
Q3 		$1.72M Sell
60,172
-249,339
-81% -$6.35M ﹤0.01% 1848
2024
Q2 		$6.74M Buy
309,511
+46,703
+18% +$1.04M ﹤0.01% 1136
2024
Q1 		$5.82M Buy
262,808
+106,978
+69% +$2.33M ﹤0.01% 1204
2023
Q4 		$3.36M Buy
155,830
+141,792
+1,010% +$2.5M ﹤0.01% 1425
2023
Q3 		$237K Buy
14,038
+3,177
+29% +$55.6K ﹤0.01% 2666
2023
Q2 		$149K Sell
10,861
-4,370
-29% -$88.5K ﹤0.01% 3051
2023
Q1 		$346K Buy
15,231
+4,336
+40% +$106K ﹤0.01% 2706
2022
Q4 		$256K Buy
10,895
+162
+2% +$3.76K ﹤0.01% 2824
2022
Q3 		$280K Sell
10,733
-510
-5% -$14.3K ﹤0.01% 2737
2022
Q2 		$247K Sell
11,243
-1,009
-8% -$23.4K ﹤0.01% 3051
2022
Q1 		$549K Sell
12,252
-1,558
-11% -$64.4K ﹤0.01% 2691
2021
Q4 		$592K Sell
13,810
-9,024
-40% -$472K ﹤0.01% 2729
2021
Q3 		$1.52M Buy
22,834
+7,462
+49% +$525K ﹤0.01% 2321
2021
Q2 		$1.13M Buy
15,372
+3,658
+31% +$242K ﹤0.01% 2692
2021
Q1 		$802K Buy
11,714
+1,383
+13% +$104K ﹤0.01% 2812
2020
Q4 		$693K Buy
10,331
+1,256
+14% +$68.1K ﹤0.01% 2689
2020
Q3 		$467K Buy
9,075
+4,015
+79% +$179K ﹤0.01% 2675
2020
Q2 		$191K Buy
5,060
+1,727
+52% +$59K ﹤0.01% 3164
2020
Q1 		$99K Buy
3,333
+2,019
+154% +$60.9K ﹤0.01% 3253
2019
Q4 		$44K Buy
1,314
+291
+28% +$7.12K ﹤0.01% 4022
2019
Q3 		$16K Buy
+1,023
New +$22.7K ﹤0.01% 4393

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's CSTL Position: Q2 2026 in Review

Deutsche Bank increased its Castle Biosciences (CSTL) stake by 25% in Q2 2026, buying an estimated $133K and bringing the position to 30,139 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Deutsche Bank first reported a position in CSTL in Q3 2019 and has held it in 28 quarters since. The position peaked at $6.74M in Q2 2024. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Deutsche Bank held 30,139 shares of Castle Biosciences worth $719K as of Q2 2026.
  • Deutsche Bank bought 5,975 Castle Biosciences shares in Q2 2026, an estimated $133K.
  • Castle Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2568 holding.
  • Deutsche Bank first reported a position in Castle Biosciences in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's Castle Biosciences position peaked at $6.74M in Q2 2024.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.